Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Lifecore Biomedical, Inc. \De\ (LFCR) Return on Invested Capital (2016 - 2025)

Historic Return on Invested Capital for Lifecore Biomedical, Inc. \De\ (LFCR) over the last 16 years, with Q2 2025 value amounting to 0.13%.

  • Lifecore Biomedical, Inc. \De\'s Return on Invested Capital fell 600.0% to 0.13% in Q2 2025 from the same period last year, while for May 2025 it was 0.13%, marking a year-over-year decrease of 600.0%. This contributed to the annual value of 0.13% for FY2025, which is 500.0% down from last year.
  • Lifecore Biomedical, Inc. \De\'s Return on Invested Capital amounted to 0.13% in Q2 2025, which was down 600.0% from 0.16% recorded in Q1 2025.
  • In the past 5 years, Lifecore Biomedical, Inc. \De\'s Return on Invested Capital ranged from a high of 0.0% in Q4 2021 and a low of 0.35% during Q3 2023
  • Its 5-year average for Return on Invested Capital is 0.11%, with a median of 0.1% in 2024.
  • As far as peak fluctuations go, Lifecore Biomedical, Inc. \De\'s Return on Invested Capital crashed by -3000bps in 2023, and later surged by 2500bps in 2024.
  • Over the past 5 years, Lifecore Biomedical, Inc. \De\'s Return on Invested Capital (Quarter) stood at 0.0% in 2021, then crashed by -79141bps to 0.13% in 2022, then plummeted by -105bps to 0.28% in 2023, then surged by 61bps to 0.11% in 2024, then fell by -23bps to 0.13% in 2025.
  • Its last three reported values are 0.13% in Q2 2025, 0.16% for Q1 2025, and 0.11% during Q4 2024.